Hypertensive Emergency vs. Urgency: The Number Is the Same. The Organ Damage Is What Determines the Response.

The Scene

The patient in this scene is a composite. Names, ages, and circumstances are changed to protect privacy.

Raymond is 58 years old and his blood pressure is 214/128 when the emergency department nurse takes it. He has had a headache for six hours, which he attributed to stress. He came to the ED because his vision went blurry while he was reading, and it did not resolve when he rubbed his eyes.

Raymond has known hypertension. He was on three medications until eighteen months ago, when he lost his insurance and stopped filling his prescriptions. He does not look acutely ill. He is alert, coherent, and his neurological examination is initially normal.

I examine his optic fundi through an ophthalmoscope. Flame hemorrhages bilaterally. Cotton-wool spots. Papilledema, grade II. The retina is showing me what his cerebral vasculature is showing me: the pressure has been this high long enough to cause end-organ injury.

His creatinine comes back at 2.8 mg/dL. It was 1.1 two years ago. His urinalysis shows 3+ protein and red blood cell casts.

The phrase “hypertensive emergency” does not mean “blood pressure is very high.” It means “blood pressure is high and organs are actively being damaged.” Raymond has hypertensive emergency. He needs intravenous therapy in a monitored ICU setting. He does not need his blood pressure brought to normal within the hour. He needs it brought down carefully, to a target that preserves what autoregulatory capacity his end-organs still have, without producing ischemic injury from too-rapid correction.

The distinction between hypertensive emergency and hypertensive urgency is not semantic. The management is different. The timeline is different. The setting is different.

What It Is

Hypertensive Emergency

Hypertensive emergency is defined as severely raised blood pressure (typically systolic above 180 mmHg or diastolic above 120 mmHg, though the exact threshold is less important than the clinical picture) in the presence of acute hypertensive end-organ damage 5 / Solid .

The critical word is “acute.” Long-standing raised blood pressure without acute progression does not constitute a hypertensive emergency, even if the numbers appear alarming in isolation. A patient with chronic blood pressure of 180/110 who has had this for three years without progression, without new symptoms, and without acute end-organ damage is not in hypertensive emergency.

The organs at acute risk in hypertensive emergency:

• Brain: Hypertensive encephalopathy, intracerebral hemorrhage, acute ischemic stroke (hypertension as a stroke trigger)
• Heart: Acute coronary syndrome precipitated by hypertension, acute left ventricular failure with pulmonary edema
• Aorta: Aortic dissection (blood pressure control is both a diagnostic and therapeutic priority)
• Kidneys: Hypertensive nephropathy with acute deterioration, thrombotic microangiopathy
• Eyes: Grade III-IV hypertensive retinopathy with papilledema, visual loss
• Uterus/placenta: Eclampsia and HELLP syndrome

Hypertensive Urgency

Hypertensive urgency is severely raised blood pressure without evidence of acute end-organ damage. The blood pressure may be 200/120, but the patient has no neurological symptoms, no chest pain, no signs of pulmonary edema, no retinal hemorrhages, no acute rise in creatinine, and no symptoms suggesting acute aortic dissection.

Management of hypertensive urgency does not require intravenous therapy, ICU admission, or rapid blood pressure reduction. It requires oral therapy with a restart or intensification of the antihypertensive regimen, close follow-up within 24-72 hours, and reassessment of what caused the blood pressure spike 5 / Solid .

The Mechanism

Why Extremely High Blood Pressure Causes Acute Organ Damage

The normal response of vascular beds to raised systemic blood pressure is autoregulation: active constriction of arterioles to maintain constant tissue perfusion despite varying input pressures. Cerebral autoregulation, for example, maintains relatively constant cerebral blood flow across systolic pressures from approximately 60 to 150 mmHg in healthy individuals.

In chronic hypertension, this autoregulatory range shifts upward. Patients with long-standing hypertension can autoregulate to much higher pressures than normotensive individuals, which is one reason chronically hypertensive patients tolerate blood pressures that would cause encephalopathy in a previously normotensive person.

But autoregulation has an upper limit. When blood pressure exceeds the upper autoregulatory limit, vessels can no longer maintain active constriction and dilate passively. Cerebral blood flow increases directly with pressure. Hydrostatic pressure drives fluid across the blood-brain barrier. Cerebral edema results. This is the mechanism of hypertensive encephalopathy 5 / Solid .

In the kidney, the afferent arteriolar damage from extremely high pressure produces fibrinoid necrosis of vessel walls, thrombotic microangiopathy, and progressive glomerular injury. Renin release from ischemic nephrons further activates RAAS, driving blood pressure higher still, creating the accelerated-malignant hypertension spiral 5 / Solid .

In aortic dissection, acutely raised blood pressure provides the force that propagates the dissecting hematoma. The tear propagates with every systole. Blood pressure reduction is the single most important early intervention, even before imaging in suspected dissection 5 / Solid .

Eclampsia and HELLP Syndrome

Eclampsia is the obstetric hypertensive emergency. It occurs in pregnancy or the early postpartum period, characterized by new-onset hypertension with proteinuria (preeclampsia) and the addition of seizures. HELLP syndrome (Hemolysis, Raised Liver enzymes, Low Platelets) is a severe variant.

The mechanism of eclampsia involves impaired placental perfusion triggering widespread endothelial dysfunction, cerebral vasoconstriction alternating with vasodilation, and breakdown of the blood-brain barrier, producing cerebral edema and seizure activity. The treatment is magnesium sulfate for seizure prophylaxis and antihypertensive therapy to lower blood pressure (typically targeting systolic below 160 mmHg and diastolic below 110 mmHg), with delivery of the fetus as the definitive treatment 5 / Solid 05514-X).

How We Diagnose It

The Emergency Assessment

When a patient presents with severely raised blood pressure, the clinical assessment determines whether hypertensive emergency or urgency is present:

Neurological: Headache character (hypertensive headache is typically occipital, worsened in morning), confusion, visual disturbance, focal neurological deficit. Any altered consciousness requires urgent CT head to exclude intracranial hemorrhage.

Cardiovascular: Chest pain (character, radiation, severity), dyspnea, new murmur (aortic regurgitation suggesting aortic dissection), differential blood pressure between arms (dissection), ST changes on ECG.

Renal: Rising creatinine from baseline, new proteinuria, urinary casts on microscopy.

Ocular: Fundoscopic examination. Grade III (flame hemorrhages, cotton-wool spots) and grade IV (papilledema) indicate emergency. This examination is underperformed in emergency departments despite its diagnostic value.

Obstetric: In women of reproductive age, check for proteinuria, platelet count, LFTs. Pregnancy test if status unknown.

CT and Laboratory Evaluation

Standard emergency evaluation: complete metabolic panel (creatinine, electrolytes), CBC, urinalysis with microscopy, ECG, chest X-ray (pulmonary edema, widened mediastinum in dissection), troponin if chest pain is present.

CT head without contrast for suspected hemorrhagic stroke or encephalopathy. CT angiography of the chest for suspected aortic dissection. Brain MRI (FLAIR sequences) is most sensitive for hypertensive encephalopathy, showing posterior leukoencephalopathy (PRES: posterior reversible encephalopathy syndrome), but is often not immediately available.

The Evidence

The 25% Rule: Why Not Faster

The cornerstone principle of hypertensive emergency management is controlled, not rapid, blood pressure reduction. The target is to reduce mean arterial pressure (MAP) by approximately 20-25% within the first hour 5 / Solid .

This is not excessive caution. It is physiology. In a patient with chronic hypertension whose autoregulatory range has shifted upward, a rapid reduction in blood pressure can move the cerebral perfusion pressure below the lower limit of autoregulation, producing cerebral ischemia at blood pressures that would be considered normal in a healthy patient. Overly aggressive treatment of hypertensive emergency causes stroke in patients who arrived without one.

The practical target: reduce MAP by 20-25% in the first 1-2 hours, then reduce to approximately 160/100 mmHg over the next 2-6 hours, then to goal over the subsequent 24-48 hours, allowing end-organ autoregulation to recalibrate 5 / Solid .

Exception: aortic dissection. The target for aortic dissection is systolic below 120 mmHg within 20-30 minutes, because the goal is to stop propagation, and every minute of raised pressure extends the tear. This is the one hypertensive emergency where rapid reduction is explicitly indicated.

Exception: eclampsia and severe preeclampsia. Target systolic below 160 mmHg and diastolic below 110 mmHg as soon as possible, because the maternal stroke risk increases sharply above these thresholds.

Exception: hypertensive emergency with acute ischemic stroke. Blood pressure management in acute ischemic stroke being considered for thrombolysis requires careful attention: BP must be below 185/110 before tPA administration, but aggressive lowering in the absence of thrombolysis eligibility may worsen ischemic penumbra 5 / Solid .

Intravenous Agents

Nicardipine: A dihydropyridine calcium channel blocker administered as a continuous intravenous infusion. Predictable, titratable blood pressure reduction. Does not cause reflex tachycardia as prominently as nitroprusside. No cyanide toxicity. Preferred for hypertensive encephalopathy, perioperative hypertension, and most hypertensive emergencies without specific indication for other agents 5 / Solid .

Labetalol: A combined alpha- and beta-adrenergic blocker administered as IV bolus doses (20-80 mg every 10 minutes) or continuous infusion. Useful when tachycardia is a concern (beta-blockade) and in dissection (though not first-line for dissection). Not used in acute decompensated heart failure (negative inotropy), reactive airway disease, or severe bradycardia.

Clevidipine: An ultra-short-acting dihydropyridine CCB with a half-life of approximately 1 minute. Highly titratable. Particularly useful in the cardiac surgery and ICU setting where precise moment-to-moment control is needed. The ECLIPSE trials established its safety and efficacy in the perioperative setting 5 / Solid .

Nitroprusside: A vasodilator with a half-life of seconds, historically used for hypertensive emergencies. The concern: cyanide toxicity with prolonged infusion, particularly in hepatic or renal dysfunction. Nitroprusside has largely been replaced by nicardipine and clevidipine in most clinical settings. It remains in use where rapid titratability at very low cost is required.

Esmolol: An ultra-short-acting beta-1-selective blocker. Used primarily for aortic dissection (often combined with a vasodilator to first achieve rate control before reducing afterload, since vasodilation alone can increase shear force) and hypertension with tachyarrhythmia.

Hydralazine: An older vasodilator sometimes used in obstetric hypertensive emergencies. Its unpredictable, prolonged, and untitratable effect makes it inferior to labetalol and nicardipine for most emergency situations, though it remains commonly used in obstetric settings where it is familiar to providers.

The Evidence Gap

There are no large randomized controlled trials of specific intravenous antihypertensive agents against other agents for hypertensive emergency with clinical endpoints. Most of the evidence is from observational studies, small trials with surrogate endpoints (blood pressure reduction), and consensus-based guidelines. This is a real gap in the evidence base 5 / Solid .

The Patient Experience

What a Hypertensive Emergency Feels Like

The clinical picture of hypertensive emergency is highly variable. Some patients arrive with dramatic symptoms: the worst headache of their life, confusion, inability to see clearly, chest pain tearing through to the back. Others arrive with symptoms that could be attributed to many conditions: mild headache, vague chest discomfort, mild visual change.

The blood pressure number is not what creates the emergency. The organ damage is what creates the emergency. Raymond’s blood pressure of 214/128 with retinal hemorrhages, rising creatinine, and visual symptoms is a different clinical situation from a patient with identical blood pressure numbers and a completely normal examination, normal urinalysis, and normal creatinine.

Patients often ask why their blood pressure went this high if they were taking their medications. The most common answers: medication discontinuation (as in Raymond’s case), significant dietary sodium excess, medication interaction (NSAIDs, stimulants, decongestants), non-adherence, or an underlying secondary cause (primary aldosteronism presenting in crisis).

The ICU Admission

Patients with hypertensive emergency require ICU-level monitoring: continuous arterial line blood pressure monitoring (cuff measurements every few minutes are not accurate enough when precise minute-to-minute control is needed), intravenous access, cardiac monitoring, and serial neurological assessments.

The patient should expect to spend 24-48 hours in an ICU setting before transition to oral agents. The transition from IV to oral agents requires careful overlap: IV agents are not discontinued until oral agents have been started and titrated, and the patient has demonstrated oral tolerance.

Decisions and Trade-Offs

When to Admit vs. Discharge for Severe Hypertension

Emergency physicians face this decision regularly: a patient with a blood pressure of 185/110, no symptoms, normal examination. Is this a hypertensive urgency requiring admission, or can the patient be discharged with oral medications and close follow-up?

The evidence favors discharge with follow-up for asymptomatic severe hypertension (urgency) in patients who have an established cardiologist or primary care relationship, are able to take oral medications, and will return for a check within 24-48 hours 5 / Solid . Routine admission for hypertensive urgency does not improve outcomes compared to outpatient management with close follow-up.

This requires a follow-up system that actually works. In well-resourced urban settings, 24-hour follow-up is achievable. In rural settings with poor access to primary care, the safer decision may be a 24-hour observation with same-day initiation of oral therapy.

The Medication Restart

For patients with hypertensive emergency caused by abrupt discontinuation of antihypertensive therapy, the treatment priority is restarting previously effective medications at full dose, not introducing new agents. The vascular bed that was controlled on a given regimen will usually respond to reintroduction of that regimen.

The exception: when the pre-discontinuation regimen was inadequate or inappropriate for current comorbidities (for example, a patient who was on HCTZ alone and now has CKD that warrants RAAS blockade as well). Emergency management with IV agents buys time to construct a more complete oral regimen for discharge.

Clinical Synthesis

Hypertensive emergency is the downstream consequence of uncontrolled hypertension. Raymond’s story, which is the story of hundreds of thousands of Americans who lose prescription access and stop their medications, is entirely preventable.

The core clinical thesis is that cardiovascular events do not appear without warning, that hypertension is not a silent disease because science cannot see it, but because the health system does not consistently act on what it sees.

A patient who discontinues blood pressure medications because of lost insurance is not choosing to have a hypertensive emergency. The system that allows an 18-month medication gap to produce irreversible renal damage in a 58-year-old is the problem that needs solving.

The practical implications for the patients:

• Every patient on antihypertensive therapy should have a 90-day supply plan (not monthly prescriptions with repeated refill barriers)
• Every patient should know the specific number above which they should call, not wait for an appointment
• Generic antihypertensives cost $10-15 per month without insurance at most major pharmacies. The cost of a hypertensive emergency hospitalization in 2026 exceeds $15,000. The arithmetic argues for pharmacy assistance programs and patient navigation, not medication rationing.

The Emergency Department in a rural setting like Carle Foundation Hospital in Urbana is not a population health intervention. It is the last stop. The population health intervention is the upstream management that prevents Raymond from arriving there.

Extended Evidence Review: Drug Selection in Hypertensive Emergency

The Principal Intravenous Agents

The choice of intravenous agent in hypertensive emergency is determined by the specific target organ involved, the desired speed of onset and offset, and the contraindications of each drug. No single agent is correct for all presentations; the emergency and intensive care physician must match the drug to the clinical scenario.

Nicardipine: A dihydropyridine calcium channel blocker delivered as a continuous IV infusion (5-15 mg/hour, titrated). Onset 5-10 minutes; offset 30-60 minutes after infusion stop. Nicardipine reduces both systolic and diastolic blood pressure through peripheral vasodilation with minimal negative chronotropic or inotropic effects. It is the preferred agent for hypertensive encephalopathy, ischemic stroke with severe hypertension (requiring treatment above the specific post-thrombolysis threshold), and perioperative hypertension. 5 / Solid

Labetalol: A combined alpha-1 and beta-1/beta-2 blocker. IV bolus (10-40 mg) or infusion (1-2 mg/min). Onset 5-10 minutes; duration 4-8 hours per bolus. Labetalol is particularly suited for aortic dissection (reduces heart rate and blood pressure simultaneously, minimizing aortic wall stress), hypertensive emergency in pregnancy (eclampsia and severe gestational hypertension; safe in second and third trimester, first-line IV agent in pregnancy-associated hypertensive emergency), and catecholamine-excess states. It should be avoided in severe bronchospasm, decompensated heart failure, high-degree AV block, and cocaine-induced hypertension (paradoxical vasoconstriction from unopposed alpha stimulation). 5 / Solid

Clevidipine: A third-generation dihydropyridine calcium channel blocker (distinct from nicardipine) with an ultra-short half-life of approximately 1 minute due to rapid esterase metabolism in red blood cells and plasma. Delivered as IV infusion, dose-response is highly predictable. Onset within 2 minutes; offset within 5 minutes after stopping. Clevidipine allows extraordinarily fine blood pressure control and is increasingly used in perioperative settings and cardiac intensive care. Its lipid emulsion formulation (similar to propofol) requires limiting infusion to 12 hours at higher doses to avoid lipid overload. 5 / Solid

Esmolol: A cardioselective beta-1 blocker with an ultra-short half-life (approximately 9 minutes; metabolized by red cell esterases). Delivered as IV bolus plus infusion. Esmolol is the preferred agent for aortic dissection when precise heart rate control is needed (target heart rate below 60 bpm), often used alongside nicardipine or sodium nitroprusside to provide both rate and pressure control. 5 / Solid

Sodium nitroprusside: An arterial and venous dilator (donor of nitric oxide) with onset within seconds and duration 2-5 minutes after stopping. Sodium nitroprusside was the historical standard for hypertensive emergency. Its primary limitation is cyanide accumulation from prolonged infusion or high doses: each nitroprusside molecule releases 5 cyanide molecules, and cyanide is metabolized to thiocyanate by hepatic rhodanase. Thiocyanate accumulates in renal failure and cyanide can accumulate in any patient on high doses for more than 24-48 hours. Thiocyanate toxicity causes confusion, tinnitus, and metabolic acidosis. In current practice, nitroprusside has largely been replaced by nicardipine and clevidipine for most indications, except in specific settings where immediate, second-by-second titration is needed (e.g., postoperative hypertension in cardiac surgery). 5 / Solid

Hydralazine: A direct arterial vasodilator given as IV bolus (10-20 mg every 20-30 minutes). Not titratable as a continuous infusion. Onset 10-30 minutes; duration 4-8 hours. The long, unpredictable duration makes hydralazine difficult to use in acute management except in pregnancy (where it has the longest safety record and is second-line after labetalol for IV therapy in eclampsia). 5 / Solid Not preferred for most hypertensive emergency presentations in non-pregnant patients due to poor titrability.

Phentolamine: An alpha-1 and alpha-2 blocker specifically indicated for catecholamine-excess emergencies: pheochromocytoma crisis, cocaine-induced hypertension, and tyramine-induced hypertensive crisis from MAO inhibitor interaction. In pheochromocytoma crisis, phentolamine is the drug of choice because it blocks the alpha-adrenergic vasoconstriction that is the primary mechanism of the hypertensive surge. 5 / Solid

The Aortic Dissection Exception

Type A aortic dissection (involving the ascending aorta) is both a hypertensive emergency requiring immediate blood pressure control and a surgical emergency requiring urgent operative repair. Type B dissection (descending aorta only) is managed medically in uncomplicated cases and interventionally (TEVAR) in complicated cases.

The blood pressure and heart rate targets for dissection are more stringent than general hypertensive emergency:

• Systolic BP target: 100-120 mmHg
• Heart rate target: below 60 bpm (slow heart rate reduces the pulsatile force: dP/dt: that propagates the dissection)
• The combination of an IV beta-blocker (esmolol) for rate control plus an arterial vasodilator (nicardipine or nitroprusside) for blood pressure control is the standard approach

The 25% MAP rule does not apply to dissection. In most hypertensive emergency presentations, the 25% MAP reduction in the first hour is the standard guideline target. For aortic dissection, this is too slow: blood pressure should be reduced to target as rapidly as possible (within minutes), because each systolic pulse while the dissection is propagating risks extension into the pericardium (cardiac tamponade), into the coronary ostia (MI), or into the carotid arteries (stroke).

Hypertensive Emergency in Pregnancy: Eclampsia and Severe Gestational Hypertension

Hypertensive emergency in pregnancy requires specific considerations because of fetal safety, placental perfusion, and the unique pathophysiology of preeclampsia and eclampsia.

Eclampsia is defined as new-onset seizure in a patient with preeclampsia. It represents cerebrovascular emergency from severe hypertension-induced posterior reversible encephalopathy syndrome (PRES). Management:

1. Magnesium sulfate IV infusion for seizure prophylaxis and treatment (not an antihypertensive; reduces neuronal excitability specifically in eclampsia)
2. Labetalol IV (first-line antihypertensive) or hydralazine IV
3. Calcium channel blocker (IV nicardipine or oral nifedipine) as alternative
4. Immediate fetal monitoring
5. Delivery as the definitive treatment: no antihypertensive regimen substitutes for delivery when the pregnancy is at or near viability

ACE inhibitors, ARBs, and direct renin inhibitors are all contraindicated in pregnancy (teratogenic: cause fetal renal failure and oligohydramnios). Sodium nitroprusside can produce fetal cyanide toxicity and is used only when all other agents fail.

The blood pressure target in severe gestational hypertension or eclampsia: systolic below 160 mmHg and diastolic below 105 mmHg to prevent intracranial hemorrhage, while maintaining adequate uteroplacental perfusion. Aggressive reduction below 140/90 in the acute setting is not recommended (uteroplacental blood flow is not autoregulated and depends on maternal perfusion pressure). 5 / Solid

Extended Patient Experience: Recognizing Hypertensive Emergency at the Front Line

The Triage Nurse’s Role

In most US hospitals, the first clinical assessment of a patient presenting with blood pressure of 210/115 is performed by a triage nurse. The critical decision at triage is: does this patient have signs of acute end-organ damage (hypertensive emergency requiring IV therapy and ICU) or do they have severely raised BP without acute organ damage (hypertensive urgency requiring oral therapy and close follow-up)?

Red flag symptoms that should prompt immediate physician evaluation and emergency workup:

• Severe headache (especially worst headache of life: subarachnoid hemorrhage), visual changes, or focal neurological deficits (stroke, hypertensive encephalopathy)
• Chest pain, back pain, or tearing sensation (aortic dissection)
• Dyspnea, orthopnea, or oxygen desaturation (acute pulmonary edema)
• Decreased level of consciousness or confusion (encephalopathy)
• Absence of urine output (acute kidney injury)
• Signs of pregnancy (preeclampsia/eclampsia)

Absence of these symptoms, with a patient who is alert, comfortable, and not in distress despite a BP of 200/115, is more consistent with hypertensive urgency than emergency, and should not routinely prompt IV therapy or ICU admission.

The Discharge Paradox: Over-Treatment of Urgency

A common error in emergency medicine is treating hypertensive urgency as an emergency: aggressively lowering blood pressure with IV medications in the emergency department, then admitting for monitoring. Multiple data show that hypertensive urgency (severely raised BP without end-organ damage) does not require emergency department blood pressure lowering and has outcomes no better than outpatient management with intensified oral therapy and follow-up within 24-48 hours. 5 / Solid

Overly aggressive treatment of urgency in the ED creates its own risks: rapid BP reduction can produce watershed ischemia in the territories most dependent on autoregulation (watershed zones of the cerebral cortex, renal medulla). For a patient with long-standing hypertension and shifted autoregulatory curves, reducing BP from 195/115 to 145/90 over two hours in the ED is not “treating” their hypertension: it is inducing a relative ischemic event in tissues adapted to higher perfusion pressure.

The appropriate approach: document the raised reading, assess for end-organ damage, resume or initiate oral antihypertensive therapy with clear follow-up instructions, and arrange reassessment within 1-7 days. Only patients with acute end-organ damage are admitted; hypertensive urgency is an outpatient condition.

Illinois Practice Context: Hypertensive Emergency Management at Carle

At Carle Foundation Hospital, hypertensive emergencies are managed in the medical intensive care unit (MICU) with continuous arterial line blood pressure monitoring for patients requiring IV titration. The cardiology service is consulted for aortic dissection, acute pulmonary edema, or STEMI-associated severe hypertension. Neurology is consulted for all hypertensive encephalopathy and hypertension-associated stroke cases.

For suspected aortic dissection, the institutional protocol triggers simultaneous: (1) cardiac surgery consultation, (2) CT angiography of the chest, abdomen, and pelvis with contrast, and (3) IV esmolol plus nicardipine initiation before imaging completion if blood pressure is above 160 mmHg systolic.

Extended Evidence Review: End-Organ Damage Presentations

Hypertensive Encephalopathy and PRES

Posterior reversible encephalopathy syndrome (PRES) is the neurological manifestation of hypertensive emergency that results from failure of cerebrovascular autoregulation. When systolic blood pressure exceeds the upper limit of autoregulation (approximately 150-180 mmHg in previously normotensive individuals, higher in chronically hypertensive patients), breakthrough hyperperfusion occurs, producing cerebral edema: predominantly in the posterior circulation territories (occipital lobes, posterior parietal lobes, cerebellum) because posterior cerebral autoregulatory reserve is physiologically lower than anterior.

MRI shows T2 FLAIR hyperintensity in posterior distributions bilaterally. The “reversible” in PRES reflects that with appropriate blood pressure control, the edema resolves and neurological deficits typically improve completely within days to weeks: provided the diagnosis is made and treatment initiated promptly. 5 / Solid

Clinical presentation: headache, visual disturbances (cortical blindness, visual field deficits), seizures, and encephalopathy: in the context of severe hypertension or other conditions that trigger autoregulatory failure (eclampsia, cyclosporine toxicity, TTP, HUS, SLE flare). The blood pressure does not need to be extremely high: PRES occurs at systolic pressures as low as 140 mmHg in patients with pre-existing endothelial dysfunction.

Treatment: blood pressure reduction (nicardipine IV for most non-pregnant patients; labetalol or hydralazine for eclampsia), seizure control if needed (benzodiazepines acutely, levetiracetam for maintenance), and treatment of the underlying triggering condition.

Hypertensive Nephrosclerosis: Acute vs Chronic

Acute hypertensive nephropathy occurs when severely raised blood pressure produces acute arteriolar necrosis in the renal vasculature, resulting in acute kidney injury with hematuria, proteinuria, and a characteristic “onion skin” arteriolar histopathology. The serum creatinine rises acutely, and without blood pressure reduction, progression to oliguric renal failure can occur within days.

The clinical picture that distinguishes acute hypertensive nephropathy from chronic hypertensive nephrosclerosis:

• Acute: rapid rise in creatinine over hours to days, urine sediment with dysmorphic red cells and red cell casts (evidence of glomerular inflammation), proteinuria
• Chronic: slow, progressive rise in creatinine over years, bland urinalysis (few cells, minimal casts), isosthenuria (inability to concentrate urine), bilateral small kidneys on imaging

Blood pressure control in acute hypertensive nephropathy should follow the 25% MAP reduction rule: rapid normalization risks ischemic nephropathy in a kidney that has adjusted to hypertensive perfusion pressures. Nicardipine is appropriate; avoid sodium nitroprusside if possible given cyanide risk with prolonged use.

Aortic Dissection: The Diagnostic Imperative

Aortic dissection requires immediate diagnosis because its management (surgical repair for Type A, medical management for uncomplicated Type B) depends on the classification, and because missed dissection is uniformly fatal. The clinical presentation can mimic MI (when the dissection involves the coronary ostia), stroke (when the dissection extends into the arch vessels), or mesenteric ischemia (when abdominal vessels are involved).

The Stanford classification:

• Type A: Involves the ascending aorta (with or without arch and descending involvement). Requires emergency surgical repair. Mortality without surgery: 1-2% per hour in the first 24 hours.
• Type B: Involves only the descending aorta (below the left subclavian). Managed medically in uncomplicated cases (no malperfusion, no rapid expansion, no rupture). TEVAR (thoracic endovascular aortic repair) for complicated Type B.

The D-dimer is highly sensitive for aortic dissection in low-to-intermediate risk patients (NOPE study showed D-dimer below 500 ng/mL had 100% sensitivity for ruling out dissection in patients below 65 years old). 4 / Promising However, CT angiography of the chest, abdomen, and pelvis with contrast remains the definitive diagnostic test.

Extended Patient Experience: Eclampsia and Peripartum Hypertensive Emergency

Preeclampsia to Eclampsia: The Clinical Spectrum

Hypertension in pregnancy deserves a dedicated section because the pathophysiology, management targets, and drug choices differ substantially from non-pregnant adults. Preeclampsia affects approximately 5-7% of pregnancies and is defined by new-onset hypertension (above 140/90 mmHg) after 20 weeks gestation with either proteinuria or end-organ dysfunction (thrombocytopenia, renal insufficiency, raised liver enzymes, pulmonary edema, or new-onset headache not explained otherwise).

Eclampsia is the addition of seizures to this picture, occurring in approximately 0.1-0.5% of preeclamptic patients. Eclampsia can occur antepartum, intrapartum, or postpartum (up to 4-6 weeks after delivery in late-onset cases).

The underlying pathophysiology of preeclampsia involves placental ischemia, release of antiangiogenic factors (sFlt-1, endoglin) that impair maternal endothelial function, and the consequent vasoconstriction, proteinuria, and systemic inflammation. The fundamental “cure” is delivery. Blood pressure management is supportive: preventing maternal cerebral complications (PRES, hemorrhagic stroke, eclampsia) while maintaining placental perfusion for fetal viability.

Drug Selection for Acute Severe Hypertension in Pregnancy

Standard antihypertensive agents for non-pregnant patients: ACE inhibitors, ARBs, nitroprusside, renin inhibitors: are contraindicated in pregnancy due to fetal toxicity (renal dysgenesis, oligohydramnios) or placental toxicity.

The approved drug choices for acute severe hypertension (above 160/110 mmHg) in pregnancy:

IV labetalol: 20 mg IV bolus, repeat at 20-40 mg every 10 minutes (max 300 mg), then continuous infusion if needed. Alpha and beta blockade reduces both peripheral resistance and cardiac output; it does not impair uterine blood flow at standard doses and has a long safety record in pregnancy. First-line at most US academic centers.

IV hydralazine: 5-10 mg IV bolus, repeat every 20 minutes (max 30 mg). Hydralazine dilates arterioles, reducing maternal BP while maintaining uterine blood flow. Historically the most widely used agent for acute pregnancy hypertension. More variable pharmacokinetics than labetalol, with higher risk of maternal hypotension if overshoot occurs.

Oral nifedipine immediate-release: 10 mg orally, repeated every 20 minutes (max 3 doses). Commonly used in low-resource settings and when IV access is delayed. There were early concerns about interaction with magnesium sulfate, but systematic reviews have not confirmed a clinically significant interaction.

Magnesium sulfate: Not an antihypertensive: its role in eclampsia management is seizure prophylaxis and treatment, not blood pressure reduction. The Magpie Trial (2002, n=10,141) established that magnesium sulfate reduces eclampsia risk by 58% in preeclamptic women (HR 0.42, 95% CI 0.29-0.60) and reduces maternal death by 45%. 5 / Solid 08938-8) Magnesium is administered concurrently with antihypertensive therapy in acute severe preeclampsia, not instead of it.

Blood pressure targets in pregnancy: reduce systolic BP from above 160 to 140-150 mmHg, diastolic from above 110 to 90-100 mmHg. Do not target normal adult blood pressure ranges: the pregnant uterus depends on high maternal BP for adequate perfusion, and overshooting to systolic below 130 mmHg risks fetal distress.

Extended Mechanism: The Cerebral Autoregulation Failure in PRES

Autoregulatory Curves: Individual Variation Matters

The concept of a fixed autoregulatory range (approximately 60-150 mmHg MAP) applies to normotensive adults. In patients with long-standing hypertension, the entire autoregulatory curve shifts rightward: the lower limit of autoregulation rises (requiring higher MAP to maintain cerebral perfusion) and the upper limit also rises (tolerating higher MAP before breakthrough hyperperfusion occurs).

This rightward shift explains why:

1. Patients with chronic severe hypertension (systolic 160-180 mmHg) may not develop PRES until blood pressure reaches 200-220 mmHg
2. Chronic hypertensives treated aggressively with rapid BP reduction can develop cerebral ischemia at systolic pressures of 130-140 mmHg: a pressure that would be completely safe in a normotensive person
3. Young patients without chronic hypertension (eclampsia, acute glomerulonephritis, TTP) can develop PRES at systolic pressures as low as 150-160 mmHg

The therapeutic implication of rightward autoregulatory shifting: the 25% MAP reduction target in the first hour is a pragmatic rule that respects the possibility of a shifted curve. The exact threshold varies between individuals. Clinical monitoring for neurological symptoms (worsening headache, new visual changes, confusion) during blood pressure reduction serves as a real-time signal that perfusion may be compromised.

Posterior Predominance of PRES: Neuroanatomy

The posterior predominance of PRES edema: occipital lobes, posterior parietal lobes, cerebellum: reflects anatomical differences in sympathetic innervation between anterior and posterior cerebral circulations. The anterior circulation (anterior cerebral artery, middle cerebral artery territories) receives denser sympathetic vasoconstriction from the cervical sympathetic chain, which provides protective vasoconstriction against high-pressure breakthrough. The posterior circulation (posterior cerebral artery, basilar artery territories) has relatively sparse sympathetic innervation, making it more susceptible to pressure-driven breakthrough hyperperfusion.

When MAP exceeds the upper limit of posterior autoregulation, forced vasodilation occurs: arterioles dilate despite high pressure, allowing high-pressure blood flow to open capillary beds that are not accustomed to full arterial pressure. The result is vasogenic edema: fluid forced from capillaries into the interstitium.

On MRI, T2-FLAIR hyperintensity in posterior distributions is the signature of PRES. The diagnosis is clinical-radiological: the combination of characteristic MRI findings with the appropriate clinical context (severe hypertension, eclampsia, immunosuppressant toxicity) and symptom reversibility with treatment. Irreversibility: incomplete resolution on follow-up MRI, persistent neurological deficit: suggests that ischemia or hemorrhagic change has occurred in addition to the edema, and carries a worse prognosis.

Quality Measures

Time to Goal: The Quality Measure

For hypertensive emergencies, the quality measure that correlates most directly with outcomes is time from presentation to initiation of IV antihypertensive therapy and time from IV therapy initiation to achieving the target blood pressure reduction (25% MAP in first hour). At Carle Foundation Hospital, the MICU protocol for hypertensive emergency includes:

1. Arterial line placement (radial preferred) within 30 minutes of MICU arrival for all patients requiring IV antihypertensive therapy
2. Nicardipine or clevidipine infusion started within 15 minutes of MICU admission
3. Target: 25% MAP reduction within 60 minutes, documented by arterial line
4. Neurology consultation within 2 hours for all hypertensive encephalopathy presentations
5. Cardiac surgery consultation within 30 minutes of suspected aortic dissection presentation

Prevention After Hypertensive Emergency

Every hypertensive emergency patient, once stabilized, is a candidate for the most intensive blood pressure education and management improvement this program offers. The hypertensive emergency is not the disease: it is the catastrophic consequence of uncontrolled or inadequately treated hypertension that was present for months or years before the presentation.

At Carle Foundation Hospital, every patient discharged after a hypertensive emergency is enrolled in the hypertension management clinic with follow-up within one week. The clinical team reviews adherence, drug regimen, home monitoring capability, and barriers to care. Insurance coverage is assessed; free or reduced-cost medication programs are initiated if needed.

This program’s position: a hypertensive emergency in a previously diagnosed hypertensive patient is a sentinel event: an indicator that the system of care failed to maintain adequate blood pressure control, not simply that the patient had severe hypertension. The system must respond with reinvestment in the management of that patient’s blood pressure going forward.

Extended Patient Experience: The Elderly Patient With Hypertensive Emergency

Unique Considerations in Older Adults

Hypertensive emergency in patients above 75 years old presents distinct challenges. Older adults are more likely to have:

• Severely shifted cerebrovascular autoregulatory curves (tolerating BP of 180/100 mmHg because their arteries have remodeled over decades)
• Compromised renal function that limits drug choices (nitroprusside avoided because of cyanide accumulation with prolonged use; hydralazine less predictable; nicardipine or clevidipine preferred)
• Polypharmacy that may interact with IV antihypertensives
• Cognitive impairment that complicates neurological assessment during BP reduction

The 25% MAP reduction target is, if anything, more critical to adhere to in elderly patients. Their rightward-shifted autoregulatory curves mean that a BP of 200/110 mmHg that looks urgent on paper may represent their “normal” adapted pressure: and reducing it to 150/90 in one hour may be ischemic for their brain and kidneys. The clinical rule: in elderly patients with chronic hypertension and hypertensive emergency, target the top of the normal range (MAP 110-120 mmHg) as the first-hour goal, not normal MAP.

Nicardipine at 5 mg/hour initial rate (not the standard 5-15 mg/hour range used in younger adults) with slower uptitration is appropriate. The arterial line response monitoring is particularly valuable in elderly patients: it prevents overshooting by providing continuous real-time feedback.

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.